Profile data is unavailable for this security.
About the company
Fresenius Medical Care AG & Co. KGaA is a Germany-based kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.
- Revenue in USD (TTM)20.93bn
- Net income in USD644.93m
- Incorporated2006
- Employees125.23k
- LocationFresenius Medical Care AG & Co KGaAElse-Kroener-Strasse 1BAD HOMBURG VOR DER HOHE 61352GermanyDEU
- Phone+49 61726090
- Fax+49 61 726092301
- Websitehttps://www.freseniusmedicalcare.com/
| Holder | Shares | % Held |
|---|---|---|
| Pzena Investment Management LLCas of 31 Mar 2023 | 20.03m | 3.41% |
| Fiduciary Management, Inc.as of 31 Mar 2023 | 5.17m | 0.88% |
| Dodge & Coxas of 31 Mar 2023 | 4.22m | 0.72% |
| Invesco Capital Management LLCas of 31 Mar 2023 | 1.33m | 0.23% |
| Parametric Portfolio Associates LLCas of 31 Mar 2023 | 954.58k | 0.16% |
| Balyasny Asset Management LPas of 31 Mar 2023 | 750.61k | 0.13% |
| Arrowstreet Capital LPas of 31 Mar 2023 | 713.62k | 0.12% |
| Jane Street Capital LLCas of 31 Mar 2023 | 607.57k | 0.10% |
| Aperio Group LLCas of 31 Mar 2023 | 485.56k | 0.08% |
| Goldman Sachs Asset Management LPas of 31 Mar 2023 | 463.96k | 0.08% |
